# Wearable Devices to Assess Effects of Central Nervous Medications on Physical Conditions in Patients With Sleep Problems

> **NCT05300386** · — · COMPLETED · sponsor: **Tri-Service General Hospital** · enrollment: 52 (actual)

## Conditions studied

- Anxiety Disorders
- Sleep Apnea

## Interventions

- **DRUG:** Escitalopram

## Key facts

- **NCT ID:** NCT05300386
- **Lead sponsor:** Tri-Service General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-30
- **Primary completion:** 2021-05-29
- **Final completion:** 2022-01-31
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2022-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05300386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05300386, "Wearable Devices to Assess Effects of Central Nervous Medications on Physical Conditions in Patients With Sleep Problems". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05300386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*